Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Advancing Multidisciplinary Care in HemophiliaRelease Date:Quality Improvement Rare Disease China BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA -
Title Grant Type Focus Area Country Application Due Date Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Rare Disease USA Project to Evaluate the Effectiveness of Elranatamab in the Treatment of Multiple MyelomaRelease Date:Partner: National Comprehensive Cancer NetworkResearch Oncology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology USA Approaches to Increase Equitable Access to and Delivery of Quality of Care with BsAb for Patients with Mutiple MyelomaRelease Date:Partner: International Myeloma FoundationQuality Improvement Oncology All Improving the care and outcomes of Canadians living with metastatic NSCLCRelease Date:Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung AssociationQuality Improvement Oncology Canada Committing to Support Elderly Cancer PatientsRelease Date:Partner: Japan Society of Clinical OncologyEducation Oncology Japan Establishing System for Early Detection of Atrial Fibrillation and Prevention of Cardioembolic StrokeRelease Date:Quality Improvement Internal Medicine Japan Improving Early Detection and Appropriate Anticoagulant Therapy for Atrial FibrillationRelease Date:Education Internal Medicine Japan Promoting Understanding of Maternal ImmunizationRelease Date:Education Vaccines Japan Promoting Understanding of Pneumonia PreventionRelease Date:Education Vaccines Japan Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid CardiomyopathyRelease Date:Education Rare Disease USA Treatment Environment of Appropriate antiviral therapy for COVID-19 InfectionsRelease Date:Education Hospital Japan